KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $8.2 million.

  • Ginkgo Bioworks Holdings' Cost of Revenue fell 1812.36% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.1 million, marking a year-over-year increase of 996.81%. This contributed to the annual value of $38.5 million for FY2024, which is 1714.17% down from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Cost of Revenue of $8.2 million as of Q3 2025, which was down 1812.36% from $9.4 million recorded in Q2 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Cost of Revenue peaked at $81.8 million during Q4 2021, and registered a low of -$870000.0 during Q4 2023.
  • Moreover, its 5-year median value for Cost of Revenue was $11.8 million (2024), whereas its average is $21.8 million.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Cost of Revenue soared by 104562.14% in 2021, and later tumbled by 10908.9% in 2023.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Cost of Revenue (Quarter) stood at $81.8 million in 2021, then tumbled by 88.29% to $9.6 million in 2022, then tumbled by 109.09% to -$870000.0 in 2023, then soared by 968.16% to $7.6 million in 2024, then increased by 8.26% to $8.2 million in 2025.
  • Its Cost of Revenue was $8.2 million in Q3 2025, compared to $9.4 million in Q2 2025 and $8.0 million in Q1 2025.